Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa
- PMID: 26283418
- PMCID: PMC4539702
- DOI: 10.1186/s12936-015-0839-4
Seasonality in malaria transmission: implications for case-management with long-acting artemisinin combination therapy in sub-Saharan Africa
Abstract
Background: Long-acting artemisinin-based combination therapy (LACT) offers the potential to prevent recurrent malaria attacks in highly exposed children. However, it is not clear where this advantage will be most important, and deployment of these drugs is not rationalized on this basis.
Methods: To understand where post-treatment prophylaxis would be most beneficial, the relationship between seasonality, transmission intensity and the interval between malaria episodes was explored using data from six cohort studies in West Africa and an individual-based malaria transmission model. The total number of recurrent malaria cases per 1000 child-years at risk, and the fraction of the total annual burden that this represents were estimated for sub-Saharan Africa.
Results: In settings where prevalence is less than 10 %, repeat malaria episodes constitute a small fraction of the total burden, and few repeat episodes occur within the window of protection provided by currently available drugs. However, in higher transmission settings, and particularly in high transmission settings with highly seasonal transmission, repeat malaria becomes increasingly important, with up to 20 % of the total clinical burden in children estimated to be due to repeat episodes within 4 weeks of a prior attack.
Conclusion: At a given level of transmission intensity and annual incidence, the concentration of repeat malaria episodes in time, and consequently the protection from LACT is highest in the most seasonal areas. As a result, the degree of seasonality, in addition to the overall intensity of transmission, should be considered by policy makers when deciding between ACT that differ in their duration of post-treatment prophylaxis.
Figures
Similar articles
-
The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.BMC Med. 2020 Feb 25;18(1):47. doi: 10.1186/s12916-020-1494-3. BMC Med. 2020. PMID: 32098634 Free PMC article.
-
Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.BMC Med. 2020 Jan 30;18(1):17. doi: 10.1186/s12916-019-1483-6. BMC Med. 2020. PMID: 31996199 Free PMC article.
-
[Treatment of pediatric malaria in Africa: act at issue].Med Trop (Mars). 2006 Jun;66(3):292-4. Med Trop (Mars). 2006. PMID: 16924825 Review. French.
-
Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.Trop Med Int Health. 2016 Feb;21(2):224-35. doi: 10.1111/tmi.12642. Epub 2015 Dec 16. Trop Med Int Health. 2016. PMID: 26578353 Free PMC article. Clinical Trial.
-
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!Acta Trop. 2005 Sep;95(3):305-15. doi: 10.1016/j.actatropica.2005.06.009. Acta Trop. 2005. PMID: 16098946 Review.
Cited by
-
Risk associations of submicroscopic malaria infection in lakeshore, plateau and highland areas of Kisumu County in western Kenya.PLoS One. 2022 May 16;17(5):e0268463. doi: 10.1371/journal.pone.0268463. eCollection 2022. PLoS One. 2022. PMID: 35576208 Free PMC article.
-
Modelling the benefits of long-acting or transmission-blocking drugs for reducing Plasmodium falciparum transmission by case management or by mass treatment.Malar J. 2017 Aug 16;16(1):341. doi: 10.1186/s12936-017-1988-4. Malar J. 2017. PMID: 28814310 Free PMC article.
-
"Man Who Won the War": Myth and Reality of Aldo Castellani's Role in Preserving the Health of Troops During the Italo-Ethiopian War 1935-1936.Adv Exp Med Biol. 2023;1370:29-53. doi: 10.1007/5584_2022_737. Adv Exp Med Biol. 2023. PMID: 35879643
-
Effect of Free Healthcare Policy for Children under Five Years Old on the Incidence of Reported Malaria Cases in Burkina Faso by Bayesian Modelling: "Not only the Ears but also the Head of the Hippopotamus".Int J Environ Res Public Health. 2020 Jan 8;17(2):417. doi: 10.3390/ijerph17020417. Int J Environ Res Public Health. 2020. PMID: 31936308 Free PMC article.
-
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention.Sci Rep. 2022 Jan 26;12(1):1402. doi: 10.1038/s41598-022-05056-7. Sci Rep. 2022. PMID: 35082312 Free PMC article.
References
-
- Taylor TE, Molyneux ME. Clinical features of malaria in children. In: Warrell DA, Gilles HM, editors. Essential malariology. London: Arnold; 2002.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
